Keros Therapeutics Inc
Keros Therapeutics Inc (KROS) Unusual Options Activity Today
KROS options volume power reached 1x on the previous trading day. The highest reading was on the $10 PUT expiring 2026-11-20.
Read more
Checking KROS unusual options activity helps you spot when traders are making outsized bets on Keros Therapeutics Inc before the broader market catches on. Keros Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor KROS unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching KROS unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking KROS unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and KROS unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, and is currently in Phase 1 clinical trial; and KER-012, which is in Phase 1 clinical trial to treat disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension.
The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Catalysts rarely arrive without a footprint, and KROS unusual options activity is often where that footprint shows up first. Our scanner tracks Keros Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at KROS unusual options volume on the call side or chasing put sweeps, Keros Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 2.50 | 6.50 | 11.00 | 8.75 | 110% | 0 | 0 | — |
| 5.00 | 4.00 | 8.50 | 6.25 | 48% | 0 | 0 | — |
| 7.50 | 1.60 | 6.00 | 3.80 | 27% | 0 | 0 | — |
| 10.00 | 0.25 | 4.90 | 2.58 | 233% | 0 | 2 | 0.00% |
| 12.50 | — | 1.30 | 1.30 | 214% | 0 | 10 | 0.00% |
| 2.50 | — | 4.90 | 4.90 | 1,000% | 0 | 0 | — |
| 5.00 | — | 0.75 | 0.75 | 570% | 0 | 0 | — |
| 7.50 | — | 0.75 | 0.75 | 350% | 0 | 0 | — |
| 10.00 | — | 0.30 | 0.30 | 117% | 0 | 27 | 0.00% |
| 12.50 | — | 2.95 | 2.95 | 301% | 0 | 0 | — |
As of October 5, 2026
Spot unusual options activity before it moves
Track KROS options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→